See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot3,994▼ 0.75%WTI103.27▲ 3.82%
← ENW page
XStocksXray
Market X-Ray report · 23 October 2026

EnWave Corporation (ENW)

TSX Venture Exchange · Canada · prices in CAD · close of 23 Oct 2026

Key indicators

Last closeCAD 0.200
52-week range0.180 – 0.440
Return, 1 month / 3 months−9.1% / −9.1%
Return, 1 year / 3 years−44.4% / −23.1%
TrendBelow its 200-day average
RSI (14)42
Volatility (1 year)77.8%
Worst drawdown (1 year)-57.1%
Average daily value traded0.01M CAD
Dividend yield–

Market X-Ray price-based

48/ 100 · High confidence · ahead of 46% of stocks on this exchange
Trend40
Momentum38
Stability (higher is calmer)60
Liquidity57
Income–

Five-year price chart navy: price · brown: 200-day average

0.120.390.660.931.202021-102023-012024-042025-072026-10

About the company

EnWave Corporation develops and licenses dehydration technology built around its radiant energy vacuum process, which removes moisture from materials at low temperatures. The company supplies equipment and licenses its technology to food producers and other manufacturers who dry products such as fruit, vegetables, dairy items and cannabis. EnWave is based in Delta, British Columbia, and works with partners and customers in several countries who use its machines for commercial drying operations.

The shares are listed on the TSX Venture Exchange in Canada under the code ENW, and the price on this page is in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

EnWave Corporation (ENW) trades on the TSX Venture Exchange in Canada. It last closed at CAD 0.200 on 23 October 2026.

Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 806 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 44.4% and over the last three months it fell 9.1%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
EnWave Corporation (ENW)

The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange

Lens and metricValueScoreReading
Trend40 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-25.0%
From 52-week high-52.4%
Momentum38 · WeakLagging most stocks on this exchange.
3-month return-9.1%
6-month return-25.9%
12-month return, skipping the last month-38.9%
Stability (higher is calmer)60 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)77.8%
Worst drawdown, 1 year (smaller is calmer)-57.1%
Liquidity57 · FairModerate trading activity.
Average daily value traded0.01M CAD
Zero-volume days5.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.

Returns

1 week−11.1%
1 month−9.1%
3 months−9.1%
6 months−25.9%
1 year−44.4%
3 years−23.1%
5 years−82.5%

Signals

50-day / 200-day average0.229 / 0.267
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.011

Technical summary

DailyStrongly bearish0 bullish · 5 neutral · 11 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 25 Oct 2026